Lucira Health Inc (Lucira Health) develops and commercializes test kits to detect infectious diseases. The company offers Lucira COVID-19 all-in-one test kit, a prescription at-home disposable molecular in vitro diagnostic testing device intended to identify novel coronavirus infection. It markets its product online. Lucira Health is headquartered in Emeryville, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Lucira Health Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Lucira Health Inc Company Overview
- Lucira Health Inc Company Snapshot
- Lucira Health Inc Pipeline Products and Ongoing Clinical Trials Overview
- Lucira Health Inc - Pipeline Analysis Overview
- Lucira Health Inc - Key Facts
- Lucira Health Inc - Major Products and Services
- Lucira Health Inc Pipeline Products by Development Stage
- Lucira Health Inc Ongoing Clinical Trials by Trial Status
- Lucira Health Inc Pipeline Products Overview
- COVID-19 Test Kit - Asymptomatic
- COVID-19 Test Kit - Asymptomatic Product Overview
- Ct/Ng POC Diagnostic Test
- Ct/Ng POC Diagnostic Test Product Overview
- Diagnostic Device - Dengue
- Diagnostic Device - Dengue Product Overview
- Diagnostic Device - Influenza
- Diagnostic Device - Influenza Product Overview
- Diagnostic Device - Zika
- Diagnostic Device - Zika Product Overview
- Influenza Diagnostic Device - Home Use
- Influenza Diagnostic Device - Home Use Product Overview
- Lucira CHECK-IT COVID-19 Test Kit
- Lucira CHECK-IT COVID-19 Test Kit Product Overview
- Lucira COVID-19 & Flu Home Test
- Lucira COVID-19 & Flu Home Test Product Overview
- Lucira COVID-19 & Flu Test - Professional Use
- Lucira COVID-19 & Flu Test - Professional Use Product Overview
- Point-Of-Care Diagnostic Test - Chlamydia Trachomatis
- Point-Of-Care Diagnostic Test - Chlamydia Trachomatis Product Overview
- Point-Of-Care Diagnostic Test - Neisseria Gonorrhoeae
- Point-Of-Care Diagnostic Test - Neisseria Gonorrhoeae Product Overview
- Point-Of-Care Diagnostic Test - Neisseria Gonorrhoeae Clinical Trial
- Portable DNA Testing Device
- Portable DNA Testing Device Product Overview
- Respiratory Syncytial Virus Test Kit
- Respiratory Syncytial Virus Test Kit Product Overview
- Self-Powered Integrated Microfluidic Blood Analysis System
- Self-Powered Integrated Microfluidic Blood Analysis System Product Overview
- Lucira Health Inc - Key Competitors
- Lucira Health Inc - Key Employees
- Lucira Health Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Lucira Health Inc, Recent Developments
- Feb 27, 2023: Lucira Health announces FDA authorization of first & only at-home combination Covid-19 & Flu test and comments on Chapter 11 bankruptcy filing
- Sep 29, 2022: Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays
- Aug 23, 2022: Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
- Aug 12, 2021: Lucira Health Announces Second Quarter 2021 Financial Results
- May 28, 2021: LUCIRA HEALTH Hires Chief Revenue Officer Kevin Collins
- Apr 29, 2021: Lucira Health celebrates grand opening of new Jabil manufacturing plant, increasing production of LUCIRA CHECK IT COVID-19 self-test
- Nov 05, 2019: Lucira Health and BARDA execute contract option for $11.5 million to bring OTC Flu Test to Market
- May 15, 2019: Lucira Health announces company rebranding and name change
- Mar 19, 2019: Diassess announces Erik T. Engelson Joins as President & Chief Executive Officer
- Jul 16, 2018: Diassess receives $21.9 million in government funding
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Lucira Health Inc Pipeline Products and Ongoing Clinical Trials Overview
- Lucira Health Inc Pipeline Products by Equipment Type
- Lucira Health Inc Pipeline Products by Indication
- Lucira Health Inc Ongoing Clinical Trials by Trial Status
- Lucira Health Inc, Key Facts
- Lucira Health Inc, Major Products and Services
- Lucira Health Inc Number of Pipeline Products by Development Stage
- Lucira Health Inc Pipeline Products Summary by Development Stage
- Lucira Health Inc Ongoing Clinical Trials by Trial Status
- Lucira Health Inc Ongoing Clinical Trials Summary
- COVID-19 Test Kit - Asymptomatic - Product Status
- COVID-19 Test Kit - Asymptomatic - Product Description
- Ct/Ng POC Diagnostic Test - Product Status
- Ct/Ng POC Diagnostic Test - Product Description
- Diagnostic Device - Dengue - Product Status
- Diagnostic Device - Dengue - Product Description
- Diagnostic Device - Influenza - Product Status
- Diagnostic Device - Influenza - Product Description
- Diagnostic Device - Zika - Product Status
- Diagnostic Device - Zika - Product Description
- Influenza Diagnostic Device - Home Use - Product Status
- Influenza Diagnostic Device - Home Use - Product Description
- Lucira CHECK-IT COVID-19 Test Kit - Product Status
- Lucira CHECK-IT COVID-19 Test Kit - Product Description
- Lucira COVID-19 & Flu Home Test - Product Status
- Lucira COVID-19 & Flu Home Test - Product Description
- Lucira COVID-19 & Flu Test - Professional Use - Product Status
- Lucira COVID-19 & Flu Test - Professional Use - Product Description
- Point-Of-Care Diagnostic Test - Chlamydia Trachomatis - Product Status
- Point-Of-Care Diagnostic Test - Chlamydia Trachomatis - Product Description
- Point-Of-Care Diagnostic Test - Neisseria Gonorrhoeae - Product Status
- Point-Of-Care Diagnostic Test - Neisseria Gonorrhoeae - Product Description
- Point-Of-Care Diagnostic Test - Neisseria Gonorrhoeae - Study to Evaluate the Performance of Combined Chlamydia Trachomatis and Neisseria Gonorrhoeae Assays
- Portable DNA Testing Device - Product Status
- Portable DNA Testing Device - Product Description
- Respiratory Syncytial Virus Test Kit - Product Status
- Respiratory Syncytial Virus Test Kit - Product Description
- Self-Powered Integrated Microfluidic Blood Analysis System - Product Status
- Self-Powered Integrated Microfluidic Blood Analysis System - Product Description
- Lucira Health Inc, Key Employees
- Glossary
- Lucira Health Inc Pipeline Products by Equipment Type
- Lucira Health Inc Pipeline Products by Development Stage
- Lucira Health Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Luminex Corp
- Epitope Diagnostics, Inc.
- CTK Biotech Inc
- Hologic Inc
- Quidel Corp
